Actym Therapeutics Appoints Thomas Smart as CEO

BERKELEY, CA — April 24, 2024 Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Officer. With 25 years of experience in senior management and executive roles as well as Board of Directors positions across the biopharmaceutical industry, Mr. Smart brings a significant […]

Article Date

This article is featured on another website.

Go to article